Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...

Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle vaccines that mimic viruses at the molecular level, offering a powerful new ...

An international research team involving the working group of biophysicist Dr. Manuel Etzkorn from Heinrich Heine University Düsseldorf (HHU) has developed an approach for using NMR spectrometry to ...

Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...

Learn how KMA and LMA represent a breakthrough in treatment approaches for multiple myeloma and related disorders.

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

(Nanowerk News) A multi-institutional research team with Northwestern Engineering’s Neha Kamat has developed a new method for rapidly assembling vaccine nanoparticles that could improve how the world ...

Scientists usually study the molecular machinery that controls gene expression from the perspective of a linear, ...